• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England.

作者信息

Hope R, Warner M, Potz N A C, Fagan E J, James D, Livermore D M

出版信息

J Antimicrob Chemother. 2006 Dec;58(6):1312-4. doi: 10.1093/jac/dkl414. Epub 2006 Oct 11.

DOI:10.1093/jac/dkl414
PMID:17035342
Abstract
摘要

相似文献

1
Activity of tigecycline against ESBL-producing and AmpC-hyperproducing Enterobacteriaceae from south-east England.替加环素对英格兰东南部产超广谱β-内酰胺酶（ESBL）和高产AmpC酶肠杆菌科细菌的活性。
J Antimicrob Chemother. 2006 Dec;58(6):1312-4. doi: 10.1093/jac/dkl414. Epub 2006 Oct 11.
2
In vitro activity of tigecycline against metallo-beta-lactamase-producing Enterobacteriaceae.替加环素对产金属β-内酰胺酶肠杆菌科细菌的体外活性。
J Antimicrob Chemother. 2007 Dec;60(6):1406-7. doi: 10.1093/jac/dkm391. Epub 2007 Oct 25.
3
Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England.替莫西林对来自英格兰东南部产超广谱β-内酰胺酶（ESBL）和AmpC酶的常见肠杆菌科细菌的活性。
J Antimicrob Chemother. 2006 May;57(5):1012-4. doi: 10.1093/jac/dkl043. Epub 2006 Mar 10.
4
Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Enterobacteriaceae.台湾地区针对替加环素对产超广谱β-内酰胺酶肠杆菌科临床分离株的体外活性开展的全国性监测。
Int J Antimicrob Agents. 2008 Nov;32 Suppl 3:S179-83. doi: 10.1016/S0924-8579(08)70024-4.
5
In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.替加环素对产超广谱β-内酰胺酶的肺炎克雷伯菌、粘质沙雷氏菌和阴沟肠杆菌临床分离株的体外活性。
J Microbiol Immunol Infect. 2008 Aug;41(4):332-6.
6
Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline.产超广谱β-内酰胺酶肠杆菌科细菌中的抗生素共耐药性及替加环素的体外活性。
Antimicrob Agents Chemother. 2006 Aug;50(8):2695-9. doi: 10.1128/AAC.00155-06.
7
In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study.体外研究替加环素对产超广谱β-内酰胺酶肠杆菌科细菌和耐甲氧西林金黄色葡萄球菌临床分离株的活性：一项多中心研究。
Diagn Microbiol Infect Dis. 2011 Jun;70(2):270-3. doi: 10.1016/j.diagmicrobio.2010.12.018.
8
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.超广谱β-内酰胺酶时代其他值得关注的抗菌药物：磷霉素、呋喃妥因和替加环素。
Clin Microbiol Infect. 2008 Jan;14 Suppl 1:198-202. doi: 10.1111/j.1469-0691.2007.01852.x.
9
Comparative in vitro activity of tigecycline against enterobacteria producing two or more extended-spectrum beta-lactamases.替加环素对产两种或更多种超广谱β-内酰胺酶肠杆菌的体外活性比较
Int J Antimicrob Agents. 2008 Dec;32(6):541-3. doi: 10.1016/j.ijantimicag.2008.06.024. Epub 2008 Sep 13.
10
Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England.伦敦及英格兰东南部肠杆菌科细菌对头孢菌素耐药的流行情况及机制
J Antimicrob Chemother. 2006 Aug;58(2):320-6. doi: 10.1093/jac/dkl217. Epub 2006 May 30.

引用本文的文献

1
Serratia Marcescens, a Rare and Devastating Cause of Endocarditis: A Case Report and Review of the Literature.粘质沙雷氏菌，一种罕见且严重的心内膜炎病因：一例病例报告及文献综述
Cureus. 2022 Jun 1;14(6):e25572. doi: 10.7759/cureus.25572. eCollection 2022 Jun.
2
Recent independent emergence of multiple multidrug-resistant Serratia marcescens clones within the United Kingdom and Ireland.近期在英国和爱尔兰境内多个多重耐药性粘质沙雷氏菌克隆株独立出现。
Genome Res. 2016 Aug;26(8):1101-9. doi: 10.1101/gr.205245.116. Epub 2016 Jul 18.
3
Clinical management of infections caused by multidrug-resistant Enterobacteriaceae.
多重耐药肠杆菌科细菌所致感染的临床管理
Ther Adv Infect Dis. 2013 Apr;1(2):49-69. doi: 10.1177/2049936113476284.
4
In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae isolates.替加环素对表型多样的大肠埃希菌和肺炎克雷伯菌分离株的体内药效学特征
Antimicrob Agents Chemother. 2009 Jul;53(7):2756-61. doi: 10.1128/AAC.01678-08. Epub 2009 Apr 13.
5
AmpC beta-lactamases.AmpC β-内酰胺酶
Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents. doi: 10.1128/CMR.00036-08.
6
In vitro activity of tigecycline against multidrug-resistant Enterobacteriaceae isolates from a Belgian hospital.替加环素对比利时一家医院分离出的耐多药肠杆菌科细菌的体外活性。
Eur J Clin Microbiol Infect Dis. 2009 Apr;28(4):381-4. doi: 10.1007/s10096-008-0629-9. Epub 2008 Sep 19.
7
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.替加环素治疗多重耐药肠杆菌科细菌感染：微生物学和临床研究证据的系统评价
J Antimicrob Chemother. 2008 Nov;62(5):895-904. doi: 10.1093/jac/dkn311. Epub 2008 Aug 1.
8
The continuing challenge of ESBLs.超广谱β-内酰胺酶的持续挑战。
Curr Opin Pharmacol. 2007 Oct;7(5):459-69. doi: 10.1016/j.coph.2007.08.003. Epub 2007 Sep 17.